Ostatní
Návod 
Akebia Therapeutics, Inc.
AKBA
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
0.4B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
-38%
ROA
-4%
PE
-71
PS
2
Cena 1R
1-4
⌀ Cena
2.66
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
Celoroční 10-K
Nadcházející oznámení zisků
12-03-2026
Poslední dividenda
Profil
Společnost Akebia Therapeutics, Inc., biofarmaceutická společnost, se zaměřuje na vývoj a komercializaci terapií pro pacienty s onemocněním ledvin. Hlavním kandidátem na přípravek je vadadustat, perorální léčba, která je ve fázi III vývoje pro léčbu anémie způsobené chronickým onemocněním ledvin (CKD) u dospělých pacientů závislých na dialýze a bez dialýzy. Nabízí také Auryxii, citronan železitý, který se používá ke kontrole sérových hladin fosforu u dospělých pacientů s DD-CKD na dialýze, a léčbu anémie nedostatku železa u dospělých pacientů s CKD, kteří nejsou na dialýze. Akebia Therapeutics, Inc. má dohody o spolupráci s Otsuka Pharmaceutical Co. Ltd. pro vývoj a komercializaci vadadustatu ve Spojených státech, Evropské unii, Rusku, Číně, Austrálii, Kanadě, na Blízkém východě a v dalších zemích; a Mitsubishi Tanabe Pharma Corporation pro vývoj a komercializaci vadadustatu v Japonsku a dalších asijských zemích, stejně jako výzkumné a licenční dohody s Janssen Pharmaceutica NV pro vývoj a komercializaci hypoxie indukovatelného faktoru prolyl hydroxyláza cílených sloučenin po celém světě. Společnost byla založena v roce 2007 a sídlí v Cambridge ve státě Massachusetts.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
181
Založení
2014-03-20
Podobné společnosti
$ 10.80
+ $ 0.24
$ 8.50
+ $ 0.15
$ 2.53
+ $ 0.17
$ 34.23
- $ 0.96
$ 10.78
+ $ 0.01
$ 8.93
+ $ 0.16
$ 9.92
- $ 0.58
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 236.2 | 236.2 | 160.2 | 194.6 | 292.6 | 213.6 | 295.3 | 335.0 | 207.7 | 178.0 | 1.5 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cost of Revenues | 39.5 | 39.5 | 63.2 | 74.1 | 84.8 | 153.4 | 295.9 | 145.3 | 7.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Gross Profit | 196.7 | 196.7 | 97.0 | 120.5 | 207.8 | 60.2 | -0.6 | 189.7 | 200.1 | 178.0 | 1.5 | 0.0 | 0.0 | 0.0 | 0.0 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 57.6 | 58.8 | 62.5 | 57.3 | 46.5 | 37.4 | 43.6 | 32.6 | 56.2 | 42.0 | |
| Cost of Revenues | 12.2 | 9.7 | 9.9 | 7.6 | 20.4 | 14.2 | 8.3 | 2.7 | 19.1 | 18.0 | |
| Gross Profit | 45.4 | 49.1 | 52.6 | 49.7 | 26.1 | 23.3 | 35.4 | 29.9 | 37.1 | 24.0 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 63.1 | 129.1 | 147.9 | 218.5 | 323.0 | 291.1 | 230.9 | 115.8 | 43.0 | 25.4 | 10.8 | 5.6 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 100.2 | 141.9 | 174.2 | 153.9 | 149.5 | 87.1 | 27.0 | 22.2 | 18.5 | 12.5 | 5.2 | 2.9 | |
| Depreciation & Amortization | 1.3 | 1.3 | 37.5 | 37.6 | 16.8 | 38.0 | 33.6 | 38.6 | 2.4 | 0.6 | 0.3 | 0.1 | 0.0 | 0.0 | 0.0 | |
| Total Operating Expenses | 173.2 | 173.2 | 147.5 | 166.7 | 271.0 | 325.5 | 375.8 | 476.0 | 378.2 | 257.9 | 138.0 | 61.5 | 37.9 | 15.9 | 8.5 | |
| Operating Income | 23.5 | 23.5 | -50.5 | -46.3 | -63.2 | -265.3 | -376.4 | -286.3 | -178.1 | -79.9 | -136.5 | -61.5 | -37.9 | -15.9 | -8.5 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 9.5 | 13.3 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 26.3 | 22.7 | ||
| Depreciation & Amortization | 0.3 | 0.3 | 0.3 | 0.3 | 9.3 | 9.4 | 9.4 | 9.4 | 9.4 | 9.4 | ||
| Total Operating Expenses | 54.0 | 44.6 | 38.5 | 36.2 | 40.4 | 35.8 | 44.1 | 44.8 | 35.8 | 36.9 | ||
| Operating Income | -8.6 | 4.4 | 14.1 | 13.5 | -14.3 | -12.5 | -8.7 | -14.9 | 1.4 | -13.0 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 6.2 | 2.8 | 0.9 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Interest Expense | 24.2 | 24.2 | 18.2 | 6.0 | 15.7 | -19.9 | -8.9 | 0.0 | 6.2 | 2.8 | 0.9 | 0.5 | 0.2 | 0.7 | -1.6 | |
| Other Expense | -27.2 | -27.2 | -18.9 | -5.7 | -29.4 | -17.5 | -7.0 | 0.0 | 6.2 | 0.2 | -0.2 | 0.3 | 0.7 | 3.5 | 2.0 | |
| IBT | -3.7 | -3.7 | -69.4 | -51.9 | -92.6 | -282.8 | -383.5 | -286.3 | -171.9 | -76.9 | -135.7 | -60.7 | -37.0 | -13.2 | -8.2 | |
| Income Tax Expense | 1.6 | 1.6 | 0.0 | 0.0 | 13.4 | -38.0 | -33.6 | -6.6 | -28.3 | -2.8 | -0.9 | -0.5 | -0.2 | 1.8 | 0.0 | |
| Net Income | -5.3 | -5.3 | -69.4 | -51.9 | -106.0 | -244.9 | -349.9 | -279.7 | -171.9 | -76.9 | -135.7 | -60.7 | -37.0 | -13.2 | -8.2 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Interest Expense | 4.8 | 4.7 | 6.8 | 7.8 | 6.9 | 6.7 | 2.1 | 2.5 | 1.4 | 1.4 | ||
| Other Expense | -2.7 | -3.3 | -13.8 | -7.4 | -8.5 | -7.5 | 0.1 | -3.0 | -0.8 | -1.5 | ||
| IBT | -11.2 | 1.2 | 0.2 | 6.1 | -22.8 | -20.0 | -8.6 | -18.0 | 0.6 | -14.5 | ||
| Income Tax Expense | 1.0 | 0.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.4 | ||
| Net Income | -12.2 | 0.5 | 0.2 | 6.1 | -22.8 | -20.0 | -8.6 | -18.0 | 0.6 | -14.5 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-0.28 | $-0.58 | $-1.48 | $-2.53 | $-2.36 | $-1.47 | $-1.77 | $-3.60 | $-2.29 | $-2.40 | $-0.68 | $-0.81 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-0.28 | $-0.58 | $-1.48 | $-2.53 | $-2.36 | $-1.47 | $-1.77 | $-3.60 | $-2.29 | $-2.40 | $-0.68 | $-0.81 | |
| Shares Outstanding | 265.4 | 257.2 | 210.9 | 187.5 | 182.8 | 165.9 | 138.5 | 118.4 | 116.9 | 43.5 | 37.7 | 26.5 | 15.4 | 19.3 | 10.1 | |
| Diluted Shares Outstanding | 265.4 | 257.2 | 210.9 | 187.5 | 182.8 | 165.9 | 138.5 | 118.4 | 116.9 | 43.5 | 37.7 | 26.5 | 15.4 | 19.3 | 10.1 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.08 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.08 | ||
| Shares Outstanding | 265.4 | 264.8 | 262.6 | 235.5 | 218.7 | 210.3 | 209.7 | 205.0 | 189.9 | 188.3 | ||
| Diluted Shares Outstanding | 265.4 | 274.4 | 271.1 | 241.6 | 218.7 | 210.3 | 209.7 | 205.0 | 190.5 | 188.3 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 39.5 | 51.9 | 42.9 | 90.5 | 149.8 | 228.7 | 147.4 | 104.6 | 70.2 | 187.3 | 49.8 | 32.8 | 21.2 | 1.6 | |
| Short Term Investments | 83.9 | 0.0 | 0.0 | 0.0 | 0.0 | 40.0 | 0.2 | 217.0 | 247.6 | 73.0 | 88.7 | 76.1 | 11.3 | 0.0 | |
| Total Cash & ST Investments | 39.5 | 51.9 | 42.9 | 90.5 | 149.8 | 268.7 | 147.7 | 321.6 | 317.8 | 260.3 | 138.5 | 108.9 | 32.6 | 1.6 | |
| Accounts Receivable | 29.8 | 34.4 | 39.3 | 39.2 | 50.9 | 26.9 | 38.9 | 16.7 | 34.2 | 33.8 | 0.0 | 0.0 | 0.1 | 0.1 | |
| Inventory | 23.9 | 16.2 | 15.7 | 21.8 | 38.2 | 61.0 | 116.3 | 114.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Assets | 19.0 | 11.4 | 20.2 | 33.5 | 33.1 | 14.9 | 6.6 | 15.7 | 6.3 | 2.2 | 2.6 | 1.5 | 0.7 | 0.5 | |
| Total Current Assets | 112.1 | 113.8 | 118.1 | 184.9 | 272.0 | 371.4 | 309.5 | 468.3 | 358.4 | 296.3 | 141.0 | 110.5 | 33.4 | 2.2 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 166.4 | 137.3 | 113.4 | 51.9 | 34.0 | 39.5 | 42.0 | 42.9 | 46.5 | 53.6 | |
| Short Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 166.4 | 137.3 | 113.4 | 51.9 | 34.0 | 39.5 | 42.0 | 42.9 | 46.5 | 53.6 | |
| Accounts Receivable | 66.2 | 72.8 | 61.5 | 34.4 | 32.2 | 29.8 | 26.6 | 39.3 | 22.6 | 19.6 | |
| Inventory | 18.6 | 16.7 | 19.7 | 16.2 | 20.5 | 23.9 | 25.5 | 15.7 | 18.4 | 20.9 | |
| Other Current Assets | 7.0 | 7.8 | 9.1 | 11.4 | 13.4 | 19.0 | 18.8 | 20.2 | 22.0 | 24.4 | |
| Total Current Assets | 258.3 | 234.7 | 203.8 | 113.8 | 100.1 | 112.1 | 112.9 | 118.1 | 109.6 | 118.4 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 13.3 | 10.4 | 16.0 | 34.4 | 40.6 | 35.5 | 39.4 | 8.0 | 3.6 | 2.6 | 0.5 | 0.2 | 0.0 | 0.0 | |
| Goodwill | 59.0 | 59.0 | 59.0 | 55.1 | 55.1 | 55.1 | 55.1 | 55.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 18.0 | 0.0 | 36.0 | 72.1 | 108.1 | 144.2 | 291.2 | 328.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 1.7 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 16.1 | 37.4 | 12.4 | 5.4 | 49.8 | 38.0 | 76.0 | 137.0 | 2.3 | 1.3 | 1.4 | 0.3 | 1.2 | 0.0 | |
| Total Long-Term Assets | 108.1 | 106.8 | 123.6 | 166.9 | 253.5 | 272.7 | 461.7 | 528.3 | 5.9 | 3.9 | 1.9 | 0.5 | 1.2 | 0.0 | |
| Total Assets | 220.2 | 220.7 | 241.7 | 351.8 | 525.6 | 644.1 | 771.2 | 996.5 | 364.2 | 300.2 | 142.9 | 111.0 | 34.7 | 2.2 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 6.3 | 7.7 | 9.0 | 10.4 | 11.8 | 13.3 | 14.7 | 16.0 | 17.4 | 18.8 | |
| Goodwill | 59.0 | 59.0 | 59.0 | 59.0 | 59.0 | 59.0 | 59.0 | 59.0 | 59.0 | 59.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.0 | 9.0 | 18.0 | 27.0 | 36.0 | 45.1 | 54.1 | |
| Long-Term Investments | 0.0 | 1.7 | 1.7 | 0.0 | 1.7 | 0.0 | 0.0 | 1.7 | 1.6 | 1.7 | |
| Other Long-Term Assets | 40.5 | 42.5 | 36.7 | 37.4 | 25.5 | 17.8 | 11.8 | -25.3 | 3.9 | 3.3 | |
| Total Long-Term Assets | 105.8 | 110.9 | 106.4 | 106.8 | 107.0 | 108.1 | 112.5 | 123.6 | 125.4 | 135.3 | |
| Total Assets | 364.2 | 345.6 | 310.2 | 220.7 | 207.1 | 220.2 | 225.5 | 241.7 | 235.0 | 253.7 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 10.1 | 15.2 | 14.6 | 18.0 | 33.6 | 41.3 | 39.2 | 42.8 | 7.0 | 2.0 | 2.3 | 2.0 | 0.7 | 0.4 | |
| Short-Term Debt | 7.2 | 9.7 | 24.0 | 36.7 | 102.3 | 5.3 | 5.0 | 15.0 | 1.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Liabilities | 32.0 | 56.0 | 61.2 | 66.3 | 99.7 | 125.3 | 124.1 | 150.9 | 51.5 | 30.3 | 9.6 | 4.9 | 3.2 | 4.5 | |
| Current Liabilities | 107.3 | 80.9 | 99.9 | 124.8 | 256.5 | 187.1 | 208.1 | 265.7 | 144.3 | 114.3 | 11.9 | 6.9 | 3.9 | 4.9 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 10.1 | 11.6 | 12.7 | 15.2 | 13.5 | 10.1 | 11.9 | 14.6 | 9.0 | 11.8 | |
| Short-Term Debt | 4.9 | 5.6 | 5.5 | 9.7 | 7.5 | 7.2 | 5.1 | 24.0 | 12.9 | 28.8 | |
| Other Current Liabilities | 114.5 | 96.0 | 71.8 | 56.0 | 44.7 | 90.0 | 48.8 | 61.2 | 34.0 | 28.3 | |
| Current Liabilities | 133.4 | 118.7 | 91.2 | 80.9 | 65.7 | 107.3 | 66.5 | 99.9 | 79.7 | 92.2 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 91.1 | 179.0 | 80.1 | 63.0 | 33.7 | 121.0 | 103.3 | 3.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Capital Leases | 6.3 | 8.9 | 8.9 | 33.7 | 38.5 | 29.9 | 32.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 1.8 | 2.4 | 1.7 | 6.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 254.0 | 269.9 | 272.3 | 342.5 | 449.1 | 396.5 | 376.4 | 360.6 | 244.9 | 232.1 | 11.9 | 6.9 | 3.9 | 4.9 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 47.6 | 47.7 | 48.6 | 179.0 | 43.3 | 97.4 | 37.8 | 80.1 | 100.9 | 86.5 | |
| Capital Leases | 4.9 | 6.3 | 7.6 | 8.9 | 10.2 | 11.5 | 12.7 | 8.9 | 15.1 | 16.2 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 8.9 | 41.1 | 41.4 | |
| Total Liabilities | 322.6 | 316.4 | 285.6 | 269.9 | 257.5 | 254.0 | 252.7 | 272.3 | 274.4 | 280.5 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -111.0 | 0.0 | 0.0 | |
| Retained Earnings | -1,635.5 | -1,678.4 | -1,609.0 | -1,552.9 | -1,460.4 | -1,177.5 | -794.1 | -514.4 | -374.1 | -297.1 | -161.4 | -100.7 | -63.7 | -59.6 | |
| Comprehensive Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.3 | -0.4 | 0.0 | -0.2 | -0.1 | 0.0 | 0.0 | |
| Total Common Equity | -33.8 | -49.2 | -30.6 | 9.3 | 76.5 | 247.6 | 394.8 | 635.9 | 119.3 | 68.1 | 131.0 | 104.1 | 30.8 | -2.7 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -1,671.5 | -1,672.0 | -1,672.2 | -1,678.4 | -1,655.6 | -1,635.5 | -1,626.9 | -1,609.0 | -1,609.6 | -1,595.1 | |
| Comprehensive Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Common Equity | 41.6 | 29.2 | 24.6 | -49.2 | -50.4 | -33.8 | -27.3 | -30.6 | -39.4 | -26.8 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 104.6 | 188.7 | 104.2 | 99.8 | 136.0 | 126.3 | 108.3 | 15.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | -33.8 | -49.2 | -30.6 | 9.3 | 76.5 | 247.6 | 394.8 | 635.9 | 119.3 | 68.1 | 131.0 | 104.1 | 30.8 | -2.7 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 41.6 | 29.2 | 24.6 | -49.2 | -50.4 | -33.8 | -27.3 | -30.6 | -39.4 | -26.8 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -40.4 | -5.3 | -69.4 | -51.9 | -92.6 | -282.8 | -383.5 | -279.7 | -143.6 | -76.9 | -135.7 | -60.7 | -37.0 | -13.2 | -8.2 | |
| Depreciation & Amortization | 37.6 | 1.3 | 37.5 | 41.8 | 37.7 | 38.0 | 33.6 | 38.6 | 2.4 | 0.6 | 0.3 | 0.1 | 0.0 | 0.0 | 0.0 | |
| Stock-Based Compensation | 7.8 | 11.3 | 7.8 | 9.3 | 17.8 | 22.7 | 24.5 | 11.9 | 19.0 | 8.9 | 5.8 | 4.7 | 6.0 | 1.6 | 0.1 | |
| Change Working Capital | -49.2 | 16.5 | -39.7 | -20.7 | -1.4 | -108.4 | -13.7 | -99.1 | 36.0 | 7.2 | 186.7 | 2.9 | 3.2 | 1.9 | -0.8 | |
| Change In Accounts Receivable | -10.2 | -14.1 | 4.0 | 1.0 | 11.7 | -24.0 | 12.0 | -22.2 | 33.4 | -0.4 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | |
| Change In Accounts Payable | 6.1 | 3.1 | -1.4 | -5.2 | 1.5 | -11.7 | 3.7 | 1.4 | 13.7 | 5.0 | -0.3 | 0.2 | 4.1 | 0.0 | 0.0 | |
| Change In Inventories | -32.7 | -23.1 | -28.4 | -2.5 | 19.8 | -25.8 | 6.2 | -29.1 | 0.0 | 16.8 | 0.0 | 0.0 | -0.8 | 0.0 | 0.0 | |
| Other Non-cash Items | 101.5 | 44.3 | 23.1 | -1.9 | -34.7 | 41.0 | 24.6 | 77.3 | 17.0 | 4.0 | 0.8 | 0.6 | 0.3 | 0.8 | 1.7 | |
| Cash from Operations | -39.0 | 0.0 | 0.0 | -23.4 | -73.2 | -253.0 | -110.4 | -257.4 | -97.5 | -56.2 | 57.9 | -52.4 | -27.5 | -11.3 | -7.2 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -12.2 | 0.5 | 0.2 | 6.1 | -22.8 | -20.0 | -8.6 | -18.0 | 0.6 | -14.5 | |
| Depreciation & Amortization | 0.3 | 0.3 | 0.3 | 0.3 | 13.5 | 9.4 | 9.4 | 9.4 | 9.4 | 9.4 | |
| Stock-Based Compensation | 3.2 | 3.2 | 2.7 | 2.2 | 0.0 | 1.6 | 0.0 | 2.4 | 1.5 | 1.8 | |
| Change Working Capital | 21.9 | 19.2 | 5.1 | -29.7 | -3.2 | -7.7 | -13.6 | -15.1 | -16.2 | -4.2 | |
| Change In Accounts Receivable | 19.1 | 6.2 | -11.5 | -27.9 | -3.1 | -2.4 | -3.1 | 12.7 | -16.7 | -3.0 | |
| Change In Accounts Payable | 10.4 | -8.8 | 3.7 | -2.2 | 2.4 | -3.0 | 6.8 | -7.5 | 4.5 | 2.3 | |
| Change In Inventories | -17.4 | 6.9 | -7.7 | -5.0 | -8.5 | -0.5 | -14.9 | -4.4 | -11.8 | -1.6 | |
| Other Non-cash Items | 18.0 | 4.8 | 14.0 | 7.5 | 8.0 | 10.0 | 2.7 | 2.0 | 46.7 | -0.4 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -2.3 | -7.2 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | -0.1 | -0.3 | -6.7 | -1.6 | -1.6 | -2.7 | -0.4 | -0.2 | 0.0 | 0.0 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 6.1 | 1.6 | 2.7 | 0.4 | 0.2 | 0.0 | 0.0 | |
| Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -99.9 | 0.0 | -224.2 | -330.6 | -147.0 | -77.2 | -77.7 | -13.4 | 0.0 | |
| Sales of Investment | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 40.0 | 60.2 | 217.8 | 256.3 | 155.0 | 162.4 | 63.9 | 12.6 | 2.0 | 1.4 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.6 | -2.7 | -0.4 | -0.2 | 0.0 | 0.0 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | 39.9 | -40.0 | 211.2 | 36.6 | -177.3 | 12.7 | -13.7 | -65.4 | -11.4 | 1.4 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.2 | -0.1 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Acquisitions | 0.2 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -15.9 | 0.0 | 0.0 | -32.0 | -33.0 | 0.0 | 0.0 | -15.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 61.8 | 188.7 | 84.5 | 36.4 | -3.3 | 9.8 | 18.0 | 108.3 | 15.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Issuance of Common Stock | 25.7 | 0.0 | 0.0 | 6.8 | 7.1 | 88.2 | 209.4 | 25.8 | 95.5 | 114.6 | 66.7 | 82.8 | 104.3 | 0.0 | 0.0 | |
| Repurchase of Common Stock | -0.8 | 0.0 | -1.3 | 0.0 | 0.0 | 0.0 | 0.0 | -0.4 | 0.0 | 0.0 | 0.0 | 0.0 | -0.2 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 6.0 | 0.0 | 0.0 | 0.0 | 40.5 | 45.5 | 22.3 | 78.6 | 1.1 | 1.7 | 0.2 | 0.4 | 0.2 | 42.3 | 2.5 | |
| Cash from Financing | 24.9 | 0.0 | 0.0 | -25.2 | 14.6 | 133.7 | 231.7 | 89.0 | 96.6 | 116.2 | 66.9 | 83.1 | 104.4 | 42.3 | 2.5 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -8.0 | 0.0 | |
| Debt Issued | 52.6 | -0.8 | -0.8 | -134.6 | 137.9 | -53.8 | 61.8 | -61.3 | 54.5 | -1.0 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 6.7 | 0.1 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | -0.1 | 0.0 | 0.0 | 0.0 | -0.8 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 6.7 | 0.0 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.3 | 0.1 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -14.1 | 133.0 | 9.0 | -48.6 | -58.7 | -79.3 | 81.3 | 42.7 | 35.7 | -117.2 | 137.6 | 17.0 | 11.6 | 19.6 | -3.4 | |
| Closing Cash Balance | 39.5 | 186.5 | 53.6 | 44.6 | 93.2 | 151.8 | 231.1 | 149.8 | 107.1 | 70.2 | 187.3 | 49.8 | 32.8 | 21.2 | 1.6 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | 18.4 | 29.1 | 23.9 | 61.5 | 17.9 | -5.5 | -2.5 | -1.0 | -3.6 | -7.1 | |
| Closing Cash Balance | 186.5 | 168.1 | 137.3 | 115.1 | 51.9 | 35.7 | 39.5 | 43.6 | 42.9 | 48.2 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -39.0 | 68.0 | -40.7 | -23.4 | -73.3 | -253.0 | -110.7 | -264.1 | -99.1 | -57.8 | 55.2 | -52.8 | -27.7 | -11.4 | -7.2 | |
| Real Free Cash Flow | -46.8 | 56.7 | -48.5 | -32.7 | -91.1 | -275.8 | -135.2 | -276.0 | -118.1 | -66.6 | 49.4 | -57.5 | -33.7 | -12.9 | -7.3 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 31.0 | 28.0 | 22.2 | -13.6 | -4.5 | -6.7 | -10.1 | -19.4 | -2.3 | -7.2 | |
| Real Free Cash Flow | 27.8 | 24.8 | 19.5 | -15.8 | -4.5 | -8.3 | -10.1 | -21.8 | -3.8 | -9.0 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -70.5 | -6 | -1.4 |
| P/S | 1.6 | 7.2 | 9.4 |
| P/B | 9.1 | 3.2 | 5.2 |
| P/FCF | 6.7 | -4.5 | -1.5 |
| Market cap | $0.4 | $0.4 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 14.4 % | 11.3 % | 0 % |
| Debt to Income | -983.7 % | -48.9 % | 0 % |
| Debt to Free cash flow | 93.3 % | -10872 % | 0 % |
| Interest expense percentage | 102.9 % | 69.8 % | 44.7 % |
| Current ratio | 1.9 | 4.9 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -12.9 % | -120.8 % | 0 % |
| ROA | -1.5 % | -31.5 % | 0 % |
| CapEx to Revenue | 0.1 % | 4.1 % | 0 % |
| RaD to Revenue | 0 % | 218.8 % | 0 % |
| ROEM | 1,304,939.2 | 520887.5 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 78.8 % | 44.3 % | 68.7 % |
| Operating margin | 7.9 % | -239.1 % | 35.5 % |
| Net margin | -7.1 % | -240.5 % | 9.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | -0 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 274.4 mil | 108.1 mil |
| Employee count | 0.2 tis | 0.2 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
